Prospect Capital's Q4 earnings edge down from prior quarter as total investment income climbs
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Bitcoin above $70k for first time since early June after Bessent's intervention in bond markets
The injection of cash boosted prospects for risky assets and came as Donald Trump urged congress to pass new laws establishing rules for crypto.
Bond markets rattle economy, sparking controversial buyback
Welcome to The Hill's Business & Economy newsletter {beacon} Business & Economy Business & Economy The Big Story Bond markets rattle economy, sparking controversial buyback The U.S.
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?
VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.
- iShares Pharma (IHE) focuses on established pharmaceutical companies
- VanEck Biotech (BBH) targets high-growth biotechnology firms
- BBH's beta is higher than IHE, indicating more volatility